AION
M VENTURES ’ NOGA YERUSHALMI ON THE ROLE OF AI IN HEALTHCARE
Noga Yerushalmi of M Ventures discusses the benefits of AI in modern healthcare and teaming up with pharma manufacturers AstraZeneca , Merck , Pfizer and Teva
WRITTEN BY : HELEN ADAMS
In the healthcare sector , M Ventures is focused on investments in biotechnology – particularly on companies that aim to build products , platforms and technologies with the potential to advance patient outcomes .
As with all investments in the modern age , M Ventures seeks to become more sustainable by supporting new technologies , services and models that can enhance sustainability – either from the use of different materials or the use of digital technologies .
M Ventures is the corporate venture capital arm of pharmaceutical manufacturer Merck , which invests in ideas formed to drive innovation . Merck , also known as MSD outside of the USA and Canada , may have been founded back in 1891 , but it uses the most cutting-edge scientific methods to improve lives all over the world and design innovative health solutions that can prevent healthcare problems and treat diseases . Particularly in light of COVID-19 , Merck is also looking at such potential problems in animals , as well as in people .
Noga Yerushalmi is the Investment Director at M Ventures , the venture capital arm of the Merck Group in Germany . She is based in Israel and her passion for healthcare started in high school .
“ I had a very good biology teacher ,” she explains . “ After military service , I did a BSc in biology .”
Following that was a successful career across life sciences and business
72 November 2022